MedPath

Blirelin

Brand Name: Blirelin

Generic Name: Leuprolide Acetate

Active
Registration Number

DRP-13946

Dosage Form

Powder For Injection (IM/SC)

Issuance Date

May 23, 2023

Expiry Date

May 23, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength3.75mg
PackagingUSP Type I clear glass vial x 5 mL with rubber stopper, aluminum seal and blue flip-off cap (drug product) + USP Type I glass ampoule x 3 mL (2 mL net content solvent) (Box of 1 vial and 1 ampoule)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Leuprolide AcetateActive
Monograph: Leuprolide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform